The imperative lies in recognizing the intricate interplay between CKD and insulin dysfunction, understanding the repercussions on overall health, and tailoring carbohydrate consumption to each patient’s distinct needs and metabolic profile. This evidence concerns the gene INS and chronic kidney disease.